Cargando…
Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis
INTRODUCTION: Chagas disease represents an important health problem with socioeconomic impacts in many Latin-American countries. It is estimated that 20% to 30% of the people infected by Trypanosoma cruzi will develop chronic Chagas cardiomyopathy (CCC), which is generally accompanied by heart failu...
Autores principales: | Menezes Junior, Antônio da Silva, Lopes, Cynthia Caetano, Cavalcante, Patrícia Freire, Martins, Edésio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cirurgia Cardiovascular
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873775/ https://www.ncbi.nlm.nih.gov/pubmed/29617506 http://dx.doi.org/10.21470/1678-9741-2017-0134 |
Ejemplares similares
-
Cardiac resynchronization therapy in patients with chronic Chagas
cardiomyopathy: long-term follow up
por: de Araújo, Edgard Ferreira, et al.
Publicado: (2014) -
Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022) -
Cardiac resynchronization therapy for patients with chronic systolic
heart failure secondary to Chagas cardiomyopathy in the 21(st)
century
por: Bestetti, Reinaldo B.
Publicado: (2014) -
Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015) -
Cognitive dysfunction in chronic Chagas disease
cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)